Skip to main content
. 2022 Feb 4;14(2):359. doi: 10.3390/pharmaceutics14020359

Table 3.

Microparticles from PLA-PEG copolymers for controlled drug delivery.

Particles Drug Treatment Reference
PLLA-PEG MPs Ibuprofen Aches and Pains [94]
PLLA-PEG-Folic acid MPs Paclitaxel and Doxorubicin Cancer [107]
PLA-PEG-PLA MPs Paclitaxel Ovarian, breast,
colon, head and neck and non-small cell lung cancers
[109]
PLLA-PEG-PLLA Morphine Cancer pains [110]
PLA-PEG-Magnetite MPs Paclitaxel Cancer-Hypothermia [111]
PLA-PEG MPs Perillyl Alcohol Glioma [115]
PEG-PLA MPs Tat-EGFP Retinal diseases [95]
PLA-PEG-PLA MPs Bone Morphogenetic protein Bone regeneration [116]
mPEG-PLA Microspheres 5-Fluorouracil Cancer [113]
PLA-PEG-PLA triblock copolymer microspheres Paclitaxel Cancer [112]